Ivabradine with Perindopril

IVA with PRN
Heart Failure
Patent oppositions filed in

Ivabradine belongs to hyperpolarization-activated cyclic nucleotide-gated(HCN)channel blocker class of drugs used to treat adults with chronic heart failure to reduce their risk of hospitalization. Perindopil is used to treat high blood pressure either alone or in combination with other medications.

This drug is missing the following documents, can you help us by contributing something?


Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
Argentina22-03-2013CILFAPre-GrantUnder ExaminationCompositionsAR081875A1View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top